Long Pepper Piperine.

Curcumin is almost entirely glucuronidated in the gut wall and liver before reaching circulation. Piperine inhibits those UGT enzymes, which raises plasma curcumin by an order of magnitude and is why the two are formulated together.

Resveratrol is cleared rapidly by glucuronidation and sulfation in the intestinal wall. Piperine slows the same conjugation step and keeps more of the parent molecule in circulation.

Piperine increases the permeability of the intestinal brush border and slows first-pass metabolism, raising the systemic appearance of fat-soluble carotenoids. Beta carotene is one of the earliest documented examples.

CoQ10 is a large lipophilic molecule with poor and variable uptake. Piperine raises its systemic exposure through the same brush border and first-pass effects it has on other fat-soluble compounds.

EGCG is heavily conjugated and effluxed back into the gut lumen before absorption. Piperine slows the glucuronidation and inhibits the efflux transporters, raising the amount that reaches circulation.

Long pepper, black pepper and ginger form trikatu, the classical Ayurvedic carrier blend used to raise the systemic exposure of whatever it accompanies. The three pungent principles all act on gut permeability and first-pass metabolism.

Both supply the same alkaloid, piperine, so combining them stacks one molecule rather than adding a second mechanism. Total piperine across the formula is the figure that matters.

Boswellic acids are poorly absorbed and heavily subject to first-pass handling. Piperine raises their systemic exposure, which is why joint formulas commonly pair the two.

Berberine has very low oral bioavailability largely because P-glycoprotein pumps it back into the gut lumen. Piperine inhibits that transporter and raises the fraction absorbed.

Quercetin is rapidly sulfated and glucuronidated in the enterocyte. Piperine inhibits both conjugating routes and raises circulating quercetin.

Piperine raises systemic exposure to several lipophilic compounds by inhibiting intestinal and hepatic glucuronidation and by acting on efflux transport at the enterocyte. Astaxanthin is a fat soluble xanthophyll that depends on micellar solubilisation and the same absorptive route. The mechanism is well characterised for the class; astaxanthin itself has not been paired with piperine in a published human trial.

Lutein is absorbed as part of a mixed micelle and then handled by transporters and conjugating enzymes piperine is documented to modify. Co-formulation with a piperine extract is common in eye support products on that basis. The class mechanism is solid; the specific pairing rests on it rather than on a lutein plus piperine trial.

Zeaxanthin travels with lutein through the same micellar and transporter dependent path that piperine acts on. Practically it means a piperine containing product changes the exposure per milligram rather than the milligrams on the label. Grounded in class pharmacology, not a dedicated trial.

Lycopene absorption is limited by micellar solubilisation and by intestinal metabolism, both points where piperine intervenes. Isomer form and food matrix already move lycopene exposure considerably, so piperine is one variable among several. Class level evidence.

Pterostilbene is cleared largely by glucuronidation and sulfation, the conjugation steps piperine slows. That predicts higher and longer systemic exposure from the same dose, which is the same reasoning behind the older resveratrol pairing. Predicted from enzyme pharmacology; not measured as a pair in people.

Lipoic acid is rapidly metabolised and conjugated after oral dosing, and piperine slows conjugating enzyme activity in the gut wall and liver. Whether that translates into a meaningful exposure change for this particular molecule has not been tested. Early, and offered as a mechanism to check rather than a known effect.

Ubiquinol shares the fat dependent absorption route of the oxidised form and the same intestinal handling piperine modifies. Ubiquinol is also oxidation sensitive, so its formulation constraints are separate from the absorption question. The enhancement mechanism carries over from the coenzyme Q10 literature; the reduced form has not been trialled with piperine.

Silybin exposure after an oral dose is limited mainly by extensive glucuronidation and sulfation rather than by poor dissolution alone, which places it squarely in the enzyme class piperine inhibits. This is the same rationale that produced the curcumin pairing. Mechanistically coherent, and not yet measured as a combination in people.

Melatonin is cleared principally by CYP1A2, and piperine inhibits several cytochrome P450 isoforms including CYP1A2 and CYP3A4. Slower clearance means higher exposure and possibly more next morning grogginess from an unchanged dose. Flagged as an exposure interaction, not as a benefit.

Caffeine is a classic CYP1A2 substrate and piperine inhibits that isoform, so the same caffeine dose taken with a piperine extract can sit in circulation longer. People who are sensitive to caffeine timing are the ones who notice. This is an interaction to plan around rather than to add.

St John's wort induces CYP3A4 and P-glycoprotein through pregnane X receptor activation, while piperine inhibits both. The two pull in opposite directions on the same handling machinery, so combining them makes the exposure of anything else taken alongside unpredictable. This is a reason to separate them, and a reason to raise piperine with any prescriber.

Tocopherols need bile, micelle formation and enterocyte handling to be absorbed, the same steps piperine acts on, and they are also cleared by conjugation. Dietary fat in the same meal remains the larger determinant. The pairing is plausible from established absorption physiology.

Preformed vitamin A is absorbed by the fat dependent route piperine influences, and the older piperine literature concerns beta-carotene specifically rather than retinyl esters. Because vitamin A has a defined upper intake level, a change in exposure per milligram matters in both directions. Early, and worth counting toward total intake.

MK-7 is highly lipophilic with a long circulating half life and depends on lipid co-ingestion for absorption, the step piperine acts at. No study has measured MK-7 exposure with and without piperine. Early, and included because the two turn up in the same multi-ingredient products.

Piperine is itself lipophilic, and so are most of the compounds it is added to enhance. A medium chain lipid vehicle keeps both in solution through gastric transit and supports micelle formation in the duodenum. The lipid and the piperine act at different points of the same absorption problem, which is why they are often used together.

Taking a piperine containing product with a fat source raises micellar solubilisation of any lipophilic co-ingredient, and a fish oil serving supplies that fat. The interaction is nutritional timing rather than chemistry between the two molecules. Straightforward and often overlooked.

Piperine is described in the pharmacology literature as stimulating digestive secretions and gastrointestinal enzyme activity. A supplemental enzyme blend delivers hydrolytic activity directly instead. The two approach the same function from different sides and have not been studied together.

Piperine is a pungent alkaloid that can irritate gastric mucosa at higher concentrations, and betaine hydrochloride lowers gastric pH. Together they load the same tissue, which is worth knowing for anyone prone to reflux. Practical caution rather than a research finding.

Long pepper appears in Ayurvedic formulations as a yogavahi, an agent added to carry other herbs, and ashwagandha is among the botanicals it is traditionally combined with. Withanolides are lipophilic and conjugation cleared, so the modern absorption rationale points the same way. Traditional use plus class mechanism; no trial of the pair.

Bacopa is another botanical long pepper is combined with in traditional formulations, and bacosides are large glycosides with limited absorption. Whether piperine changes bacoside exposure has not been measured. Included as traditional pairing with a plausible modern mechanism, at early confidence.

Oral iron salts already irritate gastric mucosa and piperine is a pungent alkaloid acting on the same surface, so taking a concentrated extract with an iron dose can compound gastrointestinal complaints. This concerns tolerability rather than iron absorption, which is governed by ascorbate, phytate and calcium. Practical note, not an absorption claim.